Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
United Nations convention on the rights of persons with disabilities needs to be interpreted on the basis of scientific evidence regarding psychiatry.
Members Of The Epa Executive Committee, Galderisi S, Gorwood P, Gaebel W, Kurimay T, Dom G, Beezhold J; Members of the EPA Committee on Ethical Issues; Wasserman D, Bailey S, Hanon C, Heinz A, Sartorius N, van der Gaag RJ, Vavrusova L, Wise J. Members Of The Epa Executive Committee, et al. Among authors: vavrusova l. Eur Psychiatry. 2018 Jun;51:87-89. doi: 10.1016/j.eurpsy.2018.05.008. Eur Psychiatry. 2018. PMID: 29885750 No abstract available.
Compulsory admissions of patients with mental disorders: State of the art on ethical and legislative aspects in 40 European countries.
Wasserman D, Apter G, Baeken C, Bailey S, Balazs J, Bec C, Bienkowski P, Bobes J, Ortiz MFB, Brunn H, Bôke Ö, Camilleri N, Carpiniello B, Chihai J, Chkonia E, Courtet P, Cozman D, David M, Dom G, Esanu A, Falkai P, Flannery W, Gasparyan K, Gerlinger G, Gorwood P, Gudmundsson O, Hanon C, Heinz A, Dos Santos MJH, Hedlund A, Ismayilov F, Ismayilov N, Isometsä ET, Izakova L, Kleinberg A, Kurimay T, Reitan SK, Lecic-Tosevski D, Lehmets A, Lindberg N, Lundblad KA, Lynch G, Maddock C, Malt UF, Martin L, Martynikhin I, Maruta NO, Matthys F, Mazaliauskiene R, Mihajlovic G, Peles AM, Miklavic V, Mohr P, Ferrandis MM, Musalek M, Neznanov N, Ostorharics-Horvath G, Pajević I, Popova A, Pregelj P, Prinsen E, Rados C, Roig A, Kuzman MR, Samochowiec J, Sartorius N, Savenko Y, Skugarevsky O, Slodecki E, Soghoyan A, Stone DS, Taylor-East R, Terauds E, Tsopelas C, Tudose C, Tyano S, Vallon P, Van der Gaag RJ, Varandas P, Vavrusova L, Voloshyn P, Wancata J, Wise J, Zemishlany Z, Öncü F, Vahip S. Wasserman D, et al. Among authors: vavrusova l. Eur Psychiatry. 2020 Aug 24;63(1):e82. doi: 10.1192/j.eurpsy.2020.79. Eur Psychiatry. 2020. PMID: 32829740 Free PMC article.
Reducing the treatment gap for mental disorders: a WPA survey.
Patel V, Maj M, Flisher AJ, De Silva MJ, Koschorke M, Prince M; WPA Zonal and Member Society Representatives. Patel V, et al. World Psychiatry. 2010 Oct;9(3):169-76. doi: 10.1002/j.2051-5545.2010.tb00305.x. World Psychiatry. 2010. PMID: 20975864 Free PMC article.
Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study.
Stein DJ, Ahokas A, Jarema M, Avedisova AS, Vavrusova L, Chaban O, Gruget C, Olivier V, Picarel-Blanchot F, de Bodinat C. Stein DJ, et al. Among authors: vavrusova l. Eur Neuropsychopharmacol. 2017 May;27(5):526-537. doi: 10.1016/j.euroneuro.2017.02.007. Epub 2017 Mar 12. Eur Neuropsychopharmacol. 2017. PMID: 28298261 Free article. Clinical Trial.
Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries.
Szkultecka-Dębek M, Miernik K, Stelmachowski J, Jakovljević M, Jukić V, Aadamsoo K, Janno S, Bitter I, Tolna J, Jarema M, Jankovic S, Pecenak J, Vavrusova L, Tavčar R, Walczak J, Talbot D, Augustyńska J. Szkultecka-Dębek M, et al. Among authors: vavrusova l. Psychiatr Danub. 2016 Sep;28(3):234-242. Psychiatr Danub. 2016. PMID: 27658832 Free article.
Schizophrenia causes significant burden to patients' and caregivers' lives.
Szkultecka-Dębek M, Miernik K, Stelmachowski J, Jakovljević M, Jukić V, Aadamsoo K, Janno S, Bitter I, Tolna J, Jarema M, Jankovic S, Pecenak J, Vavrusova L, Tavčar R, Walczak J, Talbot D, Augustyńska J. Szkultecka-Dębek M, et al. Among authors: vavrusova l. Psychiatr Danub. 2016 Jun;28(2):104-10. Psychiatr Danub. 2016. PMID: 27287783 Free article.
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder.
Stein DJ, Khoo JP, Ahokas A, Jarema M, Van Ameringen M, Vavrusova L, Hӧschl C, Bauer M, Bitter I, Mosolov SN, Olivier V, Matharan S, Picarel-Blanchot F, de Bodinat C. Stein DJ, et al. Among authors: vavrusova l. Eur Neuropsychopharmacol. 2018 Aug;28(8):970-979. doi: 10.1016/j.euroneuro.2018.05.006. Epub 2018 Jul 6. Eur Neuropsychopharmacol. 2018. PMID: 30135032 Clinical Trial.